Statins for the primary prevention of cardiovascular disease
"The reason why statin treatment may result in cancer is probably not an effect of the drug, but that low cholesterol predisposes to cancer. Thus, nine cohort studies including more than 140 000 individuals found that cancer was inversely associated with cholesterol measured 10–30 years earlier, and the association persisted after exclusion of cancer cases appearing during the first 4 year."
====================================================================
Read the complete article here.
The title 'Credible Evidence' is a key statement to what this blog is all about primarily in the arena of Heart Disease, Cholesterol and Statins.
Showing posts with label Cochrane. Show all posts
Showing posts with label Cochrane. Show all posts
Wednesday, February 12, 2014
Thursday, May 30, 2013
Are We Over-Treating High Blood Pressure? - Peter Lipson
Forbes is not my usual go-to for my medical posts here but I thought this was an article worthy of note. Here is a small quote from the article. Please read the complete
================================================================
Are We Over-Treating High Blood Pressure?
By: Peter Lipson,
Heath argues that this is too aggressive, and that we over-treat people whose BPs run in the 140-160/90s range. She bases her opinion on a recent review published by the Cochrane Collaboration, an evidence-based medicine group that keeps an eye on such things. The review included data from four studies (they use fairly strict selection criteria).
Cochrane’s conclusions were fairly clear: when data from the four studies were analyzed, the treatment of mild hypertension did not prevent important outcomes such as heart attack and stroke, but did cause side-effects.
At what level to treat high blood pressure is a hugely important question, given it’s impact on the nation’s health. As I said above, we’re talking about people who don’t already have other heart risks, and we’re talking about whether or not to commit them to long-term treatment. We’re also talking about patients who have not been able to bring their pressures down through proper diet and exercise (which, unfortunately, is a whole lot of people).
So what evidence is there to treat so-called low risk people with mild high blood pressure?
====================================================================
Read the complete article here.
================================================================
Are We Over-Treating High Blood Pressure?
By: Peter Lipson,
Heath argues that this is too aggressive, and that we over-treat people whose BPs run in the 140-160/90s range. She bases her opinion on a recent review published by the Cochrane Collaboration, an evidence-based medicine group that keeps an eye on such things. The review included data from four studies (they use fairly strict selection criteria).
Cochrane’s conclusions were fairly clear: when data from the four studies were analyzed, the treatment of mild hypertension did not prevent important outcomes such as heart attack and stroke, but did cause side-effects.
At what level to treat high blood pressure is a hugely important question, given it’s impact on the nation’s health. As I said above, we’re talking about people who don’t already have other heart risks, and we’re talking about whether or not to commit them to long-term treatment. We’re also talking about patients who have not been able to bring their pressures down through proper diet and exercise (which, unfortunately, is a whole lot of people).
So what evidence is there to treat so-called low risk people with mild high blood pressure?
====================================================================
Read the complete article here.
Subscribe to:
Posts (Atom)